The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome

被引:175
作者
Godschalk, PCR
Heikema, AP
Gilbert, M
Komagamine, T
Ang, CW
Glerum, J
Brochu, D
Li, JJ
Yuki, N
Jacobs, BC
van Belkum, A
Endtz, HP
机构
[1] Univ Med Ctr, Dept Med Microbiol & Infect Dis, Erasmus MC, NL-3015 GD Rotterdam, Netherlands
[2] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada
[3] Dokkyo Univ, Sch Med, Dept Neurol, Shimotsuga, Tochigi, Japan
[4] Univ Med Ctr, Dept Neurol, Erasmus MC, NL-3015 GD Rotterdam, Netherlands
[5] Univ Med Ctr, Dept Immunol, Erasmus MC, NL-3015 GD Rotterdam, Netherlands
关键词
D O I
10.1172/JCI200415707
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Molecular mimicry of Campylobacter jejuni lipo-oligosaccharides (LOS) with gangliosides in nervous tissue is considered to induce cross-reactive antibodies that lead to Guillain-Barre syndrome (GBS), an acute polyneuropathy. To determine whether specific bacterial genes are crucial for the biosynthesis of ganghoside-like structures and the induction of anti-ganglioside antibodies, we characterized the C jejuni LOS biosynthesis gene locus in GBS-associated and control strains. We demonstrated that specific types of the LOS biosynthesis gene locus are associated with GBS and with the expression of ganglioside-mimicking structures. Campylobacter knockout mutants of 2 potential GBS marker genes, both involved in LOS sialylation, expressed truncated LOS structures without sialic acid, showed reduced reactivity with GBS patient serum, and failed to induce an anti-ganglioside antibody response in mice. We demonstrate, for the first time, to our knowledge, that specific bacterial genes are crucial for the induction of anti-ganglioside antibodies.
引用
收藏
页码:1659 / 1665
页数:7
相关论文
共 37 条
[1]   Mechanisms of disease: Molecular mimicry and autoimmunity. [J].
Albert, LJ ;
Inman, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (27) :2068-2074
[2]   A case of Guillain-Barre syndrome following a family outbreak of Campylobacter jejuni enteritis [J].
Ang, CW ;
van Doorn, PA ;
Endtz, HP ;
Merkies, ISJ ;
Jacobs, BC ;
de Klerk, MA ;
van Koningsveld, R ;
van der Meche, FGA .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 111 (1-2) :229-233
[3]   Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barre, and Miller Fisher patients [J].
Ang, CW ;
Laman, JD ;
Willison, HJ ;
Wagner, ER ;
Endtz, HP ;
De Klerk, MA ;
Tio-Gillen, AP ;
Van den Braak, N ;
Jacobs, BC ;
Van Doorn, PA .
INFECTION AND IMMUNITY, 2002, 70 (03) :1202-1208
[4]   The Guillain-Barre syndrome: a true case of molecular mimicry [J].
Ang, CW ;
Jacobs, BC ;
Laman, JD .
TRENDS IN IMMUNOLOGY, 2004, 25 (02) :61-66
[5]   Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barre syndrome [J].
Bowes, T ;
Wagner, ER ;
Boffey, J ;
Nicholl, D ;
Cochrane, L ;
Benboubetra, M ;
Conner, J ;
Furukawa, K ;
Furukawa, K ;
Willison, HJ .
INFECTION AND IMMUNITY, 2002, 70 (09) :5008-5018
[6]   SERUM ANTI-GQ(1B) IGG ANTIBODY IS ASSOCIATED WITH OPHTHALMOPLEGIA IN MILLER FISHER SYNDROME AND GUILLAIN-BARRE-SYNDROME - CLINICAL AND IMMUNOHISTOCHEMICAL STUDIES [J].
CHIBA, A ;
KUSUNOKI, S ;
OBATA, H ;
MACHINAMI, R ;
KANAZAWA, I .
NEUROLOGY, 1993, 43 (10) :1911-1917
[7]   Structural analysis of the sialyltransferase CstII from Campylobacter jejuni in complex with a substrate analog [J].
Chiu, CPC ;
Watts, AG ;
Lairson, LL ;
Gilbert, M ;
Lim, D ;
Wakarchuk, WW ;
Withers, SG ;
Strynadka, NCJ .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (02) :163-170
[8]   Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barre and Miller-Fisher syndromes are of diverse genetic lineage, serotype, and flagella type [J].
Dingle, KE ;
Van den Braak, N ;
Colles, FM ;
Price, LJ ;
Woodward, DL ;
Rodgers, FG ;
Endtz, HP ;
Van Belkum, A ;
Maiden, MCJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (09) :3346-3349
[9]  
Endtz HP, 2000, J CLIN MICROBIOL, V38, P2297